Related Experiment Video
Updated: May 21, 2025
05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
427
Nephrology: What You May Have Missed in 2024
Abdulla Alfadhel1, Razan Alfarsi1, Hussa Alkhajah1
1Division of Nephrology, McMaster University, Hamilton, Ontario, Canada (A.A., R.A., H.A., J.C.).
Annals of Internal Medicine
|March 31, 2025
Summary
Recent nephrology studies in 2024 show semaglutide and SGLT-2 inhibitors impact chronic kidney disease (CKD) progression and cardiovascular events. New treatments also address heart failure, albuminuria, and fracture risk in CKD patients.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Pharmacology
Background:
- Non-nephrologist physicians require updates on key nephrology research.
- Advances in understanding and managing chronic kidney disease (CKD) are crucial.
Purpose of the Study:
- To summarize significant 2024 nephrology studies relevant to non-specialists.
- To highlight new findings on CKD progression, cardiovascular events, and treatment strategies.
Main Methods:
- Review of selected 2024 nephrology publications.
- Analysis of studies focusing on specific drug classes (semaglutide, SGLT-2 inhibitors) and conditions (CKD, heart failure, albuminuria, nephrolithiasis, contrast-induced nephropathy, UTIs).
Main Results:
- Semaglutide and SGLT-2 inhibitors show effects on CKD progression, cardiovascular events, and nephrolithiasis.
- Mineralocorticoid receptor agonists, avenciguat, and oral phosphate binders offer potential CKD management improvements.
- Inorganic nitrate may reduce contrast-induced nephropathy risk.
- Cefepime-taniborbactam demonstrates efficacy in complicated urinary tract infections.
Conclusions:
- New pharmacotherapies are emerging for CKD and related complications.
- Physicians should be aware of these advancements for comprehensive patient care.
- Evidence supports novel approaches to managing cardiovascular risk and specific renal conditions.
Related Concept Videos
01:33Hormonal Regulation
32.8K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.8K
01:32Filtration and Urine Formation
49.0K
The function of the kidneys is to filter, reabsorb, secrete, and excrete. Every day the kidneys filter nearly 180 liters of blood, initially removing water and solutes but ultimately returning nearly all filtrates into circulation with the help of osmoregulatory hormones. This process removes wastes and toxins but is also crucial to maintain water and electrolyte levels. Most of these functions are performed by the tiny but numerous nephrons contained within the kidneys.
49.0K
01:11Renal Failure: Dose Adjustments
51
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
51
01:28Renal Drug Excretion: Tubular Secretion
101
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
101
01:45Kidney Structure
68.3K
The kidneys are two large bean-shaped organs located in the upper abdomen. They filter the blood several times a day to remove toxins and rebalance water and electrolytes of the circulatory system via the renal veins. The kidneys receive blood directly from the heart via the renal arteries. These arteries enter the kidney at the hilum, the concave surface of the bean, where they branch and divide into smaller vessels and capillaries.
68.3K
01:10Nephrons
1.9K
The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
1.9K